Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension (Q42551807)

2 November 2017

title

Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension (English)

1 reference

2 November 2017

Schuman JS

1 reference

2 November 2017

publication date

1 November 1996

1 reference

2 November 2017

published in

Survey of Ophthalmology

1 reference

2 November 2017

volume

41 Suppl 1

1 reference

2 November 2017

page(s)

S27-37

1 reference

Long term effect of apraclonidine

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982029-7

7 January 2021

Clinical experience with the long-term use of 1% apraclonidine. Incidence of allergic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982029-7

7 January 2021

UK-14,304, a potent and selective α2-agonist for the characterisation of α-adrenoceptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982029-7

7 January 2021

The effect of topical clonidine on intraocular pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982029-7

7 January 2021

Average Partial Association in Three-Way Contingency Tables: A Review and Discussion of Alternative Tests

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982029-7

7 January 2021

Side Effects of alpha-Adrenergic Agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982029-7

7 January 2021

Comparison of apraclonidine and timolol in chronic open-angle glaucoma. A three-month study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982029-7

7 January 2021

The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982029-7

7 January 2021

Questions concerning the role of apraclonidine in the management of glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982029-7

7 January 2021

The efficacy of apraclonidine as an adjunct to timolol therapy. Apraclonidine Adjunctive Therapy Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982029-7

7 January 2021

Effects of brimonidine on aqueous humor dynamics in human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982029-7

7 January 2021

Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: a review of safety, efficacy, dose response, and dosing studies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982029-7

7 January 2021

Follicular conjunctivitis associated with apraclonidine

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2896%2982029-7

7 January 2021

10.1016/S0039-6257(96)82029-7

Identifiers

DOI

0 references

1 reference